WeTrials
Active, not recruiting

Acetylsalicylic Acid as Secondary Prevention in Colorectal Cancer

What is this study?

This study is testing if a daily low-dose aspirin can help prevent colorectal cancer from returning after liver surgery. Researchers want to see if this common, affordable medication can help patients live cancer-free for longer.

Who can participate?

This study is no longer enrolling. It included adults whose colorectal cancer had spread to the liver and who had surgery or local treatment to remove it with the aim of cure, and who were generally able to care for themselves. People who already took aspirin, blood thinners, certain anti-inflammatory drugs, or who had bleeding disorders could not take part.

What will happen?

Participants will be randomly assigned to take either a low-dose aspirin or an inactive pill (placebo) once a day for up to three years. You will also continue to receive your standard medical check-ups and follow your regular doctor care plan.

Where and when?

The study took place at 14 hospitals in Norway, Sweden, and Denmark, led by Oslo University Hospital. It is not recruiting new participants.

Key Points
  • 1Tests if daily low-dose aspirin helps prevent cancer from returning after liver surgery
  • 2Involves taking either aspirin or a placebo pill for up to three years
  • 3Took place at 14 hospitals in Norway, Sweden, and Denmark

Related video

Colorectal Cancer Spread to the Liver: Should You Take Aspirin After Surgery?

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Colorectal Cancer Liver MetastasesColorectal CancerLiver Metastases

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.